IE831715L - Analgesic and anti-inflammatory compositions - Google Patents

Analgesic and anti-inflammatory compositions

Info

Publication number
IE831715L
IE831715L IE831715A IE171583A IE831715L IE 831715 L IE831715 L IE 831715L IE 831715 A IE831715 A IE 831715A IE 171583 A IE171583 A IE 171583A IE 831715 L IE831715 L IE 831715L
Authority
IE
Ireland
Prior art keywords
analgesic
inflammatory
compositions
inflammatory compositions
caffeine
Prior art date
Application number
IE831715A
Other versions
IE55367B1 (en
Original Assignee
Richardson Vicks Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Vicks Inc filed Critical Richardson Vicks Inc
Publication of IE831715L publication Critical patent/IE831715L/en
Publication of IE55367B1 publication Critical patent/IE55367B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Novel analgesic and anti-inflammatory compositions of matter for use in eliciting an analgesic or anti-inflammatory response, said compositions comprising caffeine together with a selected non-narcotic analgesic/nonsteroidal anti-inflammatory drug or a selected narcotic analgesic, or both. When used in combination with the selected drugs, caffeine enhances the analgesic or anti-inflammatory response and also hastens its onset. [GB2134786A]
IE1715/83A 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine IE55367B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22

Publications (2)

Publication Number Publication Date
IE831715L true IE831715L (en) 1984-01-22
IE55367B1 IE55367B1 (en) 1990-08-29

Family

ID=23584242

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1715/83A IE55367B1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine

Country Status (15)

Country Link
JP (3) JPS59501460A (en)
AT (2) AT389226B (en)
AU (1) AU558485B2 (en)
BE (1) BE897356A (en)
CA (1) CA1217429A (en)
CH (1) CH659391A5 (en)
DE (1) DE3390116C2 (en)
FR (1) FR2530469A1 (en)
GB (1) GB2134786B (en)
IE (1) IE55367B1 (en)
IT (1) IT1206502B (en)
NL (1) NL191432C (en)
SE (1) SE466481B (en)
WO (1) WO1984000488A1 (en)
ZA (2) ZA835324B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
CH664085A5 (en) * 1985-02-08 1988-02-15 Ciba Geigy Ag PHARMACEUTICAL PREPARATIONS WITH ANALGETIC EFFECTIVENESS AND THEIR PRODUCTION.
CH669523A5 (en) * 1986-06-25 1989-03-31 Mepha Ag
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
CA2452872A1 (en) 2001-07-06 2003-01-16 Endo Pharmaceuticals, Inc. Parenteral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7914831B2 (en) * 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
JP2006282644A (en) * 2005-04-05 2006-10-19 Idemitsu Kosan Co Ltd Fatigue recovery agent
TW201247195A (en) * 2011-04-28 2012-12-01 Kowa Co Stable pharmaceutical composition
JP2018076305A (en) * 2016-10-31 2018-05-17 エスエス製薬株式会社 Pharmaceutical composition
JP2021054728A (en) * 2019-09-27 2021-04-08 興和株式会社 Pharmaceutical
JP6811453B1 (en) * 2020-06-24 2021-01-13 医療法人すぎやま内科 Composition for transdermal absorption

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
JPS5423132A (en) * 1977-07-19 1979-02-21 Dai Ichi Seiyaku Co Ltd Analgesic composition
JPS54154416A (en) * 1978-05-26 1979-12-05 Tdk Electronics Co Ltd High dielectric constant porcelain composition
US4234601A (en) * 1978-12-18 1980-11-18 Mcneilab, Inc. Analgesic potentiation
US4233316A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233317A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233314A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4233315A (en) * 1978-12-18 1980-11-11 Mcneilab, Inc. Analgesic potentiation
US4237140A (en) * 1979-05-18 1980-12-02 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and acetaminophen
US4315936A (en) * 1979-12-17 1982-02-16 Ortho Pharmaceutical Corporation Analgesic composition
JPS56154416A (en) * 1980-04-30 1981-11-30 Kaken Pharmaceut Co Ltd Antipyretic analgesic composition
US4322427A (en) * 1981-04-16 1982-03-30 Bristol-Myers Company Analgetic compositions and methods of use
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same

Also Published As

Publication number Publication date
ZA835324B (en) 1984-09-26
AU558485B2 (en) 1987-01-29
AT389226B (en) 1989-11-10
CH659391A5 (en) 1987-01-30
AU1881683A (en) 1984-02-23
JPS59501459A (en) 1984-08-16
GB2134786A (en) 1984-08-22
IE55367B1 (en) 1990-08-29
SE8401538L (en) 1984-03-20
ATA245988A (en) 1989-08-15
JPS59501460A (en) 1984-08-16
IT1206502B (en) 1989-04-27
DE3390116T1 (en) 1985-01-10
NL8320240A (en) 1984-06-01
ATA903983A (en) 1989-04-15
GB8406704D0 (en) 1984-04-18
FR2530469A1 (en) 1984-01-27
IT8322173A0 (en) 1983-07-21
AT389998B (en) 1990-02-26
GB2134786B (en) 1986-05-08
SE466481B (en) 1992-02-24
ZA835326B (en) 1984-09-26
WO1984000488A1 (en) 1984-02-16
BE897356A (en) 1983-11-14
JPH07165583A (en) 1995-06-27
NL191432B (en) 1995-03-01
NL191432C (en) 1995-07-04
DE3390116C2 (en) 1994-06-16
SE8401538D0 (en) 1984-03-20
CA1217429A (en) 1987-02-03

Similar Documents

Publication Publication Date Title
IE843166L (en) Pharmaceutical composition - xanthine derivatives
EP0229022A3 (en) Novel pharmaceutical compositions comprising analgesic agents or caffeine
IE831715L (en) Analgesic and anti-inflammatory compositions
AU7378987A (en) Drug delivery device, its preparation and use
IE882960L (en) Osmotic dosage form for administering isradipine
ATE98495T1 (en) MEDICATIONS FOR TOPICAL USE.
IE831714L (en) Analgesic and anti-inflammatory compositions
EP0304802A3 (en) Pharmaceutical composition and the use thereof
GB2170709B (en) Pharmaceutical compositions with analgesic properties and the preparation and use thereof
AU4345489A (en) Anti-inflammatory and analgesic compounds, related compositions and methods for preparation and use thereof
AU2837089A (en) New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
AU7543887A (en) Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
AU6209790A (en) Pyridinyl-quinolone compounds, their preparation and use
AU4246289A (en) Substituted 1,3,5-triazinetriones, processes for their preparation and their use against parasitic protozoa
AU2457688A (en) New fluoromethoxyphenyl dihydropyridines, processes for the preparation and their use in medicaments
AU7143887A (en) Benzimidazolesulfonamides and imidazopyridine-sulfonamides, their preparation and their application as drugs
AU3119089A (en) 3,4,5-substituted 4h-1,2,4-triazoles, the preparation and use thereof
AU570612B2 (en) Alpha-glucosidase inhibitor, its preparation and pharmaceutical use
AU560575B2 (en) Meptazinol and ibuprofen analgesic
AU8129987A (en) Pyrrolo-benzimidazoles, their preparation and use
AU1638488A (en) Organo-metal compositions, preparation and use
EP0172233A4 (en) Punaglandins and pharmaceutical use thereof.
ZA891798B (en) Pharmaceutical compositions containing quinolin-2,5-diones new quinolin-2,5-diones and the preparation thereof
GB2201591B (en) Analgesic antipyretic and anti-inflammatory compositions.
Rosen et al. San Francisco Real Estate Market: The City, the Peninsula and the East Bay

Legal Events

Date Code Title Description
MK9A Patent expired